Microbial transformation of icariin and its derivatives

Abstract Microbial transformation is an important tool to perform selective conversion of compounds to derivatives which are difficult to produce synthetically. In order to obtain icariside II and icaritin, the active components in Herba Epimedii in vivo, biotransformation studies using microbes as biocatalysts were carried out. Icariside II (2) and icaritin (3) were produced through biotransformation of icariin (1) using the fungi Hormoconis resinae and Mortierella ramanniana var. angulispora in 98% and 92% yields, respectively. In the subsequent transformation studies, 2 was deglycosylated to form 3 by Gliocladium deliquescens, whereas 3 was further converted to a novel compound icaritin-3-O-β-d-glucopyranoside (4) and previously known icaritin-3,7-O-β-d-diglucopyranoside (5) by Mucor hiemalis. Biological evaluation of these compounds using MTT assay exhibited potent cytotoxic activities against human cancer cell lines A549, A375P, and MCF-7, with icariin being the most active, indicating that glycosylation plays a role in the cytotoxic activity. Graphical Abstract

[1]  Ik-Soo Lee,et al.  Microbial Conjugation Studies of Licochalcones and Xanthohumol , 2021, International journal of molecular sciences.

[2]  C. Bailly.  Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma. , 2020, Chemico-biological interactions.

[3]  H. You,et al.  Microbial biocatalysis of quercetin-3-glucoside and isorhamnetin-3-glucoside in Salicornia herbacea and their contribution to improved anti-inflammatory activity , 2020, RSC advances.

[4]  Ik-Soo Lee,et al.  Microbial Transformation of Prenylquercetins by Mucor hiemalis , 2020, Molecules.

[5]  Xiu-Min Li,et al.  PI3K–AKT Signaling Activation and Icariin: The Potential Effects on the Perimenopausal Depression-Like Rat Model , 2019, Molecules.

[6]  Jian Chen,et al.  Efficient bioconversion of epimedin C to icariin by a glycosidase from Aspergillus nidulans. , 2019, Bioresource technology.

[7]  Lin Cai,et al.  Icariin promotes osteogenic differentiation of bone marrow stromal cells and prevents bone loss in OVX mice via activating autophagy , 2019, Journal of cellular biochemistry.

[8]  Shirui Tan,et al.  Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM , 2019, Breast Cancer.

[9]  M. Yousuf,et al.  Microbial Bioconversion: A Regiospecific Method for Novel Drug Design and Toxicological Study of Metabolites. , 2019, Current pharmaceutical biotechnology.

[10]  Tae-Hoo Yi,et al.  Icariin and icaritin recover UVB-induced photoaging by stimulating Nrf2/ARE and reducing AP-1 and NF-κB signaling pathways: a comparative study on UVB-irradiated human keratinocytes , 2018, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[11]  Guoqing Li,et al.  Local icariin application enhanced periodontal tissue regeneration and relieved local inflammation in a minipig model of periodontitis , 2018, International Journal of Oral Science.

[12]  Peng Li,et al.  Activation of PPARγ mediates icaritin-induced cell cycle arrest and apoptosis in glioblastoma multiforme. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  J. Choi,et al.  Potential of Icariin Metabolites from Epimedium koreanum Nakai as Antidiabetic Therapeutic Agents , 2017, Molecules.

[14]  Surinder P. Singh,et al.  Microbial bio transformation: a process for chemical alterations , 2017 .

[15]  Ik-Soo Lee,et al.  A new flavonol glycoside from the aerial parts of Epimedium koreanum Nakai , 2017, Natural product research.

[16]  Q. Luo,et al.  The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II , 2016, Nutrients.

[17]  Kok-Gan Chan,et al.  Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives , 2016, Front. Pharmacol..

[18]  Jinhua Xu,et al.  Icaritin, a novel FASN inhibitor, exerts anti-melanoma activities through IGF-1R/STAT3 signaling , 2016, Oncotarget.

[19]  Tong Zhang,et al.  Optimized Biotransformation of Icariin into Icariside II by β-Glucosidase from Trichoderma viride Using Central Composite Design Method , 2016, BioMed research international.

[20]  Peipei Dong,et al.  Biotransformation of major flavonoid glycosides in herb epimedii by the fungus Cunninghamella blakesleana , 2015 .

[21]  Ik-Soo Lee,et al.  Microbial transformation of bavachin by Absidia coerulea , 2015 .

[22]  Q. Mei,et al.  Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii. , 2015, Life sciences.

[23]  Caisheng Wu,et al.  A new strategy for the discovery of epimedium metabolites using high-performance liquid chromatography with high resolution mass spectrometry. , 2013, Analytica chimica acta.

[24]  Jianjun Liu,et al.  Preparation of icariside II from icariin by enzymatic hydrolysis method. , 2010, Fitoterapia.

[25]  Min Huang,et al.  Synthesis and antimultidrug resistance evaluation of icariin and its derivatives. , 2009, Bioorganic & medicinal chemistry letters.

[26]  D. Yeung,et al.  A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner , 2008, Bone.

[27]  F. Belluti,et al.  Potent inhibition of human phosphodiesterase-5 by icariin derivatives. , 2008, Journal of natural products.

[28]  Y. Lou,et al.  A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells. , 2007, European journal of pharmacology.

[29]  Y. Lou,et al.  Estrogenic effects of two derivatives of icariin on human breast cancer MCF-7 cells. , 2005, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[30]  M. Iinuma,et al.  Flavonol glycosides production in cell suspension cultures of Vancouveria hexandra , 1993 .

[31]  A. Clark,et al.  The use of microorganisms for the study of drug metabolism , 1985, Medicinal research reviews.